New anti-inflammatory mechanism of glucocorticoids uncovered

Carolyn L. Cummins*, Ido Goldstein

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

Abstract

Glucocorticoids (GCs) are potent anti-inflammatory drugs. A new study by Auger et al. found that GCs increase itaconate, an anti-inflammatory tricarboxylic acid (TCA) cycle intermediate, by promoting movement of cytosolic pyruvate dehydrogenase (PDH) to mitochondria. Itaconate was sufficient for mediating the anti-inflammatory effects of GCs in mice, overriding the notion that nuclear glucocorticoid receptor (GR) is necessary for inflammation inhibition.

Original languageEnglish
JournalTrends in Endocrinology and Metabolism
DOIs
StateAccepted/In press - 2024

Bibliographical note

Publisher Copyright:
© 2024 Elsevier Ltd

Keywords

  • GR
  • LPS
  • PDH
  • itaconate
  • macrophage

Fingerprint

Dive into the research topics of 'New anti-inflammatory mechanism of glucocorticoids uncovered'. Together they form a unique fingerprint.

Cite this